Overview

Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension

Status:
Completed

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy and safety of fixed-dose combination of nebivolol and valsartan compared to monotherapy and placebo in patients with stage 1 and stage 2 hypertension.

Phase:

Phase 3

Details

Lead Sponsor:

Forest Laboratories

Treatments:

Nebivolol
Valsartan